Department of Anesthesia, College of Medicine and Health Sciences, Bahir Dar University, Bahir Dar, Ethiopia.
BMC Public Health. 2024 Nov 12;24(1):3139. doi: 10.1186/s12889-024-20678-4.
Non-communicable diseases account for nearly three-fourths of global deaths impacting public health and development. Coexisting diseases can complicate the management of surgical diseases, increasing the risk of perioperative mortality. Despite this, few studies have examined the burden of comorbidities among surgical patients and their effect on perioperative outcomes in low-income countries. In this study, we assessed the impact of comorbidity burden on 28-day perioperative mortality using a prospective data set.
This was a facility-based prospective cohort study. Adult patients aged ≥ 18 who underwent non-cardiac surgery were included. Patients were followed for 28 days following surgery. Perioperative data were collected using an electronic data collection system from June 01, 2019, to June 30, 2021, at Tibebe Ghion Specialized Hospital, Northwest, Ethiopia. A propensity score-matched analysis was employed to assess the effect of comorbidity on the 28-day perioperative mortality rate.
Of the 3030 patients included in this study, 715 (23.59%) had at least one comorbidity. Based on the prevalence rate, the top four comorbid conditions observed were hypertension (0.050), cancer (0.036), diabetes mellitus (0.021), and human immunodeficiency virus (0.021). The 28-day perioperative mortality rate was shown to be significantly higher among patients with comorbidity, where 45 (6.29%) of the 715 patients with comorbidity died compared to 49 (2.12%) of the 2315 patients with no comorbidity (p-value < 0.0001). After propensity score matching potential confounders, patients who have comorbidity had a 2.52% (average treatment effect on treated (ATT) = 0.0252) higher risk of perioperative death at 28 days after surgery compared with patients who did not have comorbidity.
This study found a moderate prevalence of comorbid illnesses among non-cardiac surgical patients, with comorbidity increasing the risk of 28-day perioperative mortality. Preoperative screening and optimization are highly recommended for patients with comorbid illness to decrease perioperative mortality rate.
非传染性疾病占全球死亡人数的近四分之三,对公共卫生和发展造成影响。并存疾病会使外科疾病的管理复杂化,增加围手术期死亡率。尽管如此,很少有研究调查并存疾病在低收入国家的外科患者中的负担及其对围手术期结局的影响。在这项研究中,我们使用前瞻性数据集评估了并存疾病负担对 28 天围手术期死亡率的影响。
这是一项基于机构的前瞻性队列研究。纳入年龄≥18 岁并接受非心脏手术的成年患者。患者在手术后 28 天内接受随访。使用电子数据采集系统从 2019 年 6 月 1 日至 2021 年 6 月 30 日在埃塞俄比亚西北的 Tibebe Ghion 专科医院收集围手术期数据。采用倾向评分匹配分析评估并存疾病对 28 天围手术期死亡率的影响。
在这项研究中,共有 3030 名患者,其中 715 名(23.59%)至少有一种并存疾病。根据患病率,观察到的前四种并存疾病是高血压(0.050)、癌症(0.036)、糖尿病(0.021)和人类免疫缺陷病毒(0.021)。结果显示,患有并存疾病的患者的 28 天围手术期死亡率明显更高,其中 715 名患有并存疾病的患者中有 45 名(6.29%)死亡,而 2315 名无并存疾病的患者中有 49 名(2.12%)死亡(p 值<0.0001)。在进行倾向评分匹配以消除潜在混杂因素后,患有并存疾病的患者在手术后 28 天内发生围手术期死亡的风险比没有并存疾病的患者高 2.52%(平均治疗效果(ATT)=0.0252)。
本研究发现非心脏外科患者的并存疾病患病率中等,并存疾病增加了 28 天围手术期死亡率的风险。强烈建议对患有并存疾病的患者进行术前筛查和优化,以降低围手术期死亡率。